Science

FDA Approves Alzheimer’s Drug Amid Doubts Over Efficacy

GIVING IT A SHOT

The agency “will continue to monitor Aduhelm as it reaches the market and ultimately the patient’s bedside,” it said in a news release.

GettyImages-1227710766_ryz3lx
Sarah Silbiger/Getty Images

Got a tip? Send it to The Daily Beast here.